Inhibrx Biosciences

(NASDAQ) INBX

Current Price$96.93

Market Cap$1.39B

Since IPO (2024)+582%

5 YearN/A

1 Year+547%

1 Month-4%

Inhibrx Biosciences Financials at a Glance

Market Cap

$1.39B

Revenue (TTM)

$1.30M

Net Income (TTM)

-$130.19M

EPS (TTM)

-$8.39

P/E Ratio

-11.32

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$96.93

Volume

14.492

Open

$94.63

Price

$96.93

Volume

14.492

Open

$94.63

Previous Close

$94.94

Daily Range

$92.50 - $103.79

52-Week Range

$15.82 - $155.29

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$96.93

Volume

14.492

Open

$94.63

Previous Close

$94.94

Daily Range

$92.50 - $103.79

52-Week Range

$15.82 - $155.29

Estimated Earnings Date

Aug 12, 2026

INBX News

Inhibrx Biosciences Beats Earnings

Motley Fool Markets TeamAug 13, 2025

INBX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Inhibrx Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

110

CEO

Mark Paul Lappe

Website

www.inhibrx.com

Headquarters

La Jolla, CA 92037, US

INBX Financials

Key Financial Metrics (TTM)

Gross Margin

-80.38%

Operating Margin

-9465.46%

Net Income Margin

-10014.23%

Return on Equity

-563.89%

Return on Capital

-117.41%

Return on Assets

-70.77%

Earnings Yield

-8.83%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.39B

Shares Outstanding

14.67M

Volume

14.492

Avg. Volume

450.72K

Financials (TTM)

Gross Profit

-$1.05M

Operating Income

-$123.05M

EBITDA

-$117.09M

Operating Cash Flow

-$131.93M

Capital Expenditure

-$10.00K

Free Cash Flow

-$131.94M

Cash & ST Invst.

$161.66M

Total Debt

$5.90M

Inhibrx Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$537.00K

+20.4%

Gross Margin

0.00%

N/A

Market Cap

$1.39B

N/A

Market Cap/Employee

$12.78M

N/A

Employees

109

N/A

Net Income

-$33.44M

+22.8%

EBITDA

-$30.39M

+23.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$161.66M

-25.3%

Total Debt

$5.90M

-94.5%

Accounts Receivable

$186.00K

-13.1%

Inventory

$0.00

N/A

Long Term Debt

$3.50M

-96.7%

Short Term Debt

$2.41M

+22.0%

Return on Assets

-70.77%

N/A

Return on Invested Capital

-78.15%

N/A

Free Cash Flow

-$38.03M

-5.9%

Operating Cash Flow

-$38.03M

-5.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMTXImmatics N.V.

IMTXImmatics N.V.$9.97+1.22%

NKTRNektar Therapeutics

NKTRNektar Therapeutics$65.79+2.17%

AMLXAmylyx Pharmaceuticals, Inc.

AMLXAmylyx Pharmaceuticals, Inc.$18.17+1.23%

ORICORIC Pharmaceuticals, Inc.

ORICORIC Pharmaceuticals, Inc.$11.00+0.96%

CVACCureVac N.V.

CVACCureVac N.V.$4.66+0.00%

ATAIAtai Beckley Inc.

ATAIAtai Beckley Inc.$4.80-1.70%

SANASana Biotechnology, Inc.

SANASana Biotechnology, Inc.$3.64+2.11%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.50+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.88+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.46-0.04%

NOKNokia

NOKNokia$12.91-0.03%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$157.54-0.08%

SMCISuper Micro Computer

SMCISuper Micro Computer$27.65-0.06%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.34+0.02%

Questions About INBX

What is the current price of Inhibrx Biosciences?

Inhibrx Biosciences is trading at $94.94 per share.

What is the 52-week range for Inhibrx Biosciences?

Over the past 52 weeks, Inhibrx Biosciences has traded between $15.82 and $155.29.

How much debt does Inhibrx Biosciences have?

As of the most recent reporting period, Inhibrx Biosciences reported total debt of $180.90M.

How much cash does Inhibrx Biosciences have on hand?

Inhibrx Biosciences reported $161.66M in cash and cash equivalents in its most recent financial results.

What is Inhibrx Biosciences’s dividend yield?

Inhibrx Biosciences does not currently have a dividend yield.

Inhibrx Biosciences

Inhibrx Biosciences Financials at a Glance

INBX News

Inhibrx Biosciences Beats Earnings

INBX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Inhibrx Biosciences

INBX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Inhibrx Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INBX

What is the current price of Inhibrx Biosciences?

What is the 52-week range for Inhibrx Biosciences?

How much debt does Inhibrx Biosciences have?

How much cash does Inhibrx Biosciences have on hand?

What is Inhibrx Biosciences’s dividend yield?

Premium Investing Services